The Aeras Global TB Vaccine Foundation of Bethesda, MD and The University of California, Los Angeles (UCLA) announced today that the two organizations had executed a non-exclusive license for a tuberculosis vaccine technology developed at UCLA.
CGD Policy Blogs
GlaxoSmithKline said the new vaccine to protect against cervical cancer could offer wider resistance to the disease than previously thought, according to new data released yesterday. GSK say that the vaccine, called Cervarix, appeared to be effective against viruses causing 82% of cervical cancer cases following the latest trial among 700 women.
The World Malaria Report was published on 3 May. It is a comprehensive effort by the Roll Back Malaria Partnership to take stock of where the world stands in relation to one of its most devastating diseases. It reveals that the tide may be beginning to turn against malaria as control and prevention programmes start to take effect.
Bio Ventures for Global Health (BVGH) aims to accelerate the development, distribution and accessibility of biotechnology products that address diseases of the developing world. BVGH seeks to break traditional barriers to development, bridging the gap between biotechnology's immense promise and the enormous unmet health needs of the developing world.
What a thrill to take to the stage and look out and see a standing-room-only crowd at CGD's MCA Monitor: What's Next for the Millennium Challenge Account?. The crowd was a great mix of people from NGOs, the diplomatic community, the academic world, the Administration, the Hill and the MCC itself -- a reflection of the broad interest in (and scrutiny of) the MCA as an innovation for aid delivery. A few highlights of the afternoon were:
Radio Free Europe's piece, U.S 'Challenge' Aid for Tblisi Seen as Catalyst for Development offers a description of and rational for Georgia's MCA Compact proposal. According to the article, the proposal includes a major road project, the rehabilitation of a gas pipeline, and an equity fund for investments in agriculture.
Efforts to salvage the "Majengo" vaccine - the vaccine candidate based on the apparent natural immunity of prostitutes in Kenya's Majengo slums - are ending, following a continued lack of success.
See full article in AllAfrica.com.
Debt relief and African poverty are firmly on this year’s global agenda, most recently from the Tony Blair-sponsored Africa Commission. But little attention is going to the big elephant in the room: Nigeria.
Even with its oil wealth, Nigeria’s debt burden is enormous given its huge population of 130 million and its extreme poverty—average income is just $330 per year. Increasingly vital to Western energy security, Nigeria is also a worrying source of transnational security threats, including Islamic radicalism, disease, drug trafficking, and international crime.